Biomarkers: refining diagnosis and expediting drug development - reality, aspiration and the role of open innovation
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers: refining diagnosis and expediting drug development - reality, aspiration and the role of open innovation
Authors
Keywords
-
Journal
JOURNAL OF INTERNAL MEDICINE
Volume 276, Issue 3, Pages 215-228
Publisher
Wiley
Online
2014-03-08
DOI
10.1111/joim.12234
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy
- (2013) Nicola A. Hanania et al. ANNALS OF INTERNAL MEDICINE
- Circulating p53-Responsive MicroRNAs as Predictive Biomarkers in Heart Failure After Acute Myocardial Infarction
- (2013) Sarah Evans et al. CIRCULATION RESEARCH
- Identifying novel biomarkers for cardiovascular disease risk prediction
- (2013) Y. Ge et al. JOURNAL OF INTERNAL MEDICINE
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Judgment Versus Biomarker Prostate Cancer Gene 3: Which Is Best When Determining the Need for Repeat Prostate Biopsy?
- (2013) Bertrand Tombal et al. UROLOGY
- Quality of life and chronic heart failure therapy guided by natriuretic peptides: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study
- (2012) Anju Bhardwaj et al. AMERICAN HEART JOURNAL
- Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
- (2012) J Cuzick et al. BRITISH JOURNAL OF CANCER
- Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing
- (2012) M A Martin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The determination and interpretation of the therapeutic index in drug development
- (2012) Patrick Y. Muller et al. NATURE REVIEWS DRUG DISCOVERY
- Next-generation sequencing in the clinic: are we ready?
- (2012) Leslie G. Biesecker et al. NATURE REVIEWS GENETICS
- Tumor markers in prostate cancer I: Blood-based markers
- (2011) Shahrokh F. Shariat et al. ACTA ONCOLOGICA
- Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies
- (2011) Bruce J. Trock et al. BJU INTERNATIONAL
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
- (2011) J A Johnson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacoeconomic evaluation of warfarin pharmacogenomics
- (2011) Joyce HS You EXPERT OPINION ON PHARMACOTHERAPY
- Treatment of HER2-positive breast cancer: current status and future perspectives
- (2011) Carlos L. Arteaga et al. Nature Reviews Clinical Oncology
- Glycogen Storage Diseases: A Brief Review and Update on Clinical Features, Genetic Abnormalities, Pathologic Features, and Treatment
- (2011) John Hicks et al. ULTRASTRUCTURAL PATHOLOGY
- PK–PD modeling of protein drugs: implications in assay development
- (2011) Lorin K Roskos et al. Bioanalysis
- The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans
- (2010) Michael W. Weiner et al. Alzheimers & Dementia
- The role of metabolites and metabolomics in clinically applicable biomarkers of disease
- (2010) Mamas Mamas et al. ARCHIVES OF TOXICOLOGY
- MicroRNAs and Heart Failure Diagnosis
- (2010) David W. Markham et al. CIRCULATION RESEARCH
- Antipsychotic Occupancy of Dopamine Receptors in Schizophrenia
- (2010) Magdalena Nord et al. CNS Neuroscience & Therapeutics
- Towards a knowledge-based Human Protein Atlas
- (2010) Mathias Uhlen et al. NATURE BIOTECHNOLOGY
- Messy biology and the origins of evolutionary innovations
- (2010) Dan S Tawfik Nature Chemical Biology
- A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury
- (2010) Jonathan B Singer et al. NATURE GENETICS
- Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTRMutation
- (2010) Frank J. Accurso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenomic biomarkers: new tools in current and future drug therapy
- (2010) Sarah C. Sim et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- Genetic basis for idiosyncratic reactions to antiepileptic drugs
- (2009) Diego Franciotta et al. CURRENT OPINION IN NEUROLOGY
- Total and phosphorylated tau protein as biological markers of Alzheimer’s disease
- (2009) Harald Hampel et al. EXPERIMENTAL GERONTOLOGY
- MammaPrint™ 70-gene signature: another milestone in personalized medical care for breast cancer patients
- (2009) Elzbieta A Slodkowska et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Protein microarrays: high-throughput tools for proteomics
- (2009) Oda Stoevesandt et al. Expert Review of Proteomics
- How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease
- (2009) V O Puntmann POSTGRADUATE MEDICAL JOURNAL
- Potential etiologic and functional implications of genome-wide association loci for human diseases and traits
- (2009) L. A. Hindorff et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetics of Cystic Fibrosis
- (2009) Sherstin Lommatzsch et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
- New serological biomarkers of inflammatory bowel disease
- (2008) Xuhang Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Strategic Approach to Fit-for-Purpose Biomarkers in Drug Development
- (2007) John A. Wagner Annual Review of Pharmacology and Toxicology
- EAU Guidelines on Prostate Cancer
- (2007) Axel Heidenreich et al. EUROPEAN UROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started